NCT06748144View on ClinicalTrials.gov

IO Vancomycin Spine

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2030

Conditions
Lumbar Fusion Surgery
Interventions
DRUG

Intraosseous Vancomycin

The intervention is specific to the method of administration that will be used when giving the dose of antibiotic vancomycin which is done to prevent infection following surgery.

DRUG

Intravenous Vancomycin

This is the standard method of giving the antibiotic vancomycin to patients undergoing surgery across many specialties in order to prevent infection.

Trial Locations (1)

77030

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER

NCT06748144 - IO Vancomycin Spine | Biotech Hunter | Biotech Hunter